The present study delves into the intricate roles of C1QA, CD74, and HLA-DMA, exploring their interactions within the tumor microenvironment and their implications for the immunotherapy response, thereby providing new insights into the treatment of pediatric osteosarcoma. This evidence concerns the gene CD74 and neoplasm.